NetworkNewsBreaks – Applied Genetic Technologies Corporation’s (NASDAQ: AGTC) R&D Day Highlights and Insights Featured in ROTH Equity Research Report

February 3, 2020 14:06:43

Applied Genetic Technologies Corporation (NASDAQ: AGTC) was featured in a recent Equity Research Report published by ROTH Capital Partners, LLC. The report reads, “On Tuesday we attended AGTC’s R&D Day in New York. Management showcased in granular detail data from its XLRP and ACHM clinical programs. In addition, we got to hear from KOLs and patients, and got a sense of their view of what a successful gene therapy would be. With encouraging proof of concept data in hand, and manufacturing in place, AGTC is ready to accelerate development of its XLRP and ACHM programs, and advance its early stage pipeline.”

To request access to the full report, visit

About AGTC

AGTC is a clinical-stage biotechnology company that uses a proprietary gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. Its initial focus is in the field of ophthalmology, in which it has active clinical trials in X-linked retinitis pigmentosa (“XLRP”) and achromatopsia (“ACHM CNGB3 & ACHM CNGA3”). In addition to its clinical trials, AGTC has preclinical programs in optogenetics, adrenoleukodystrophy (“ALD”), which is a disease of the central nervous system (“CNS”) and other CNS, ophthalmology and indications. The optogenetics program is being developed in collaboration with Bionic Sight. The otology program is being developed in collaboration with Otonomy. AGTC has a significant intellectual property portfolio and extensive expertise in the design of gene therapy products including capsids, promoters and expression cassettes, as well as expertise in the formulation, manufacture and physical delivery of gene therapy products. For more information, visit

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published:

NetworkNewsWire (NNW)
New York, New York
212.418.1217 Office

NetworkNewsWire is part of the InvestorBrandNetwork.